Item 5.07 Submission of Matters to a Vote of Security Holders. MacroGenics, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders on May 21, 2025. A total of 52,004,843 shares of the Company's common stock were present or represented by proxy at the meeting, which represented approximately 82% of the Company's 63,090,323 shares of common stock that were outstanding and entitled to vote at the meeting as of the record date of March 24, 2025. Stockholders considered the four proposals outlined below, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 11, 2025 (the "Proxy Statement"). Proposal 1. The election of four nominees to serve as Class III directors, each for a term of three years. All director nominees were elected. The voting results were as follows: